Abstract
Objective: The purpose of this study was to determine a sterile 0.5% chloramphenicol eye drop formula with the best potency of antibacterial by determining the appropriate sterilization method and the supporting pH.
 Methods: 0.5% chloramphenicol was formulated with 0.01% thimerosal, which act as a bactericide and combines with borate buffer to produce eye drop formulas with variations in pH (6.8, 7.0 and 7.4). All formulas were stored at room temperature for 28 d and were evaluated, including: organoleptic of the preparations, sterility, pH stability, and the antibacterial potency of chloramphenicol in eye drops.
 Results: All dosage formulas did not undergo photodegradation reactions which were marked by no change in color until the end of the storage period. However, the formula with pH 6.8 which was sterilized by heating in a presence of bactericide, showed the presence of more particulate precipitates than in the pH 6.8 formula which was sterilized using membrane filter bacteria. However, both methods of sterilization produced sterile chloramphenicol eye drops. The preparation using a method of heat sterilization with bactericide decreased the pH greater than the preparation using a sterile bacterial filter sterilization method. C2 preparations at pH 7.0 and sterilized using the bacterial filter membrane sterilization method were more stable because they had the smallest pH change of 0.05 and the percentage reduction in antibacterial potential was smaller at 1.15%.
 Conclusion: The best treatment for the chloramphenicol eye drop was kept the pH formula at pH 7 and sterilized using bacterial filter membrane sterilization method.
Highlights
Eye infections occur when pathogenic microorganisms contaminated and multiply in the eye
Conjunctivitis, endophthalmitis and bacterial keratitis are some kinds of eye infection caused by various kinds of bacteria [2,3,4]
Chloramphenicol is one of the topical antibiotic occasionally used in the eye infection treatment because of its broad antibacterial spectrum and its capability to penetrate into the aqueous humor and ocular tissues [6]
Summary
Eye infections occur when pathogenic microorganisms contaminated and multiply in the eye. Chloramphenicol acts by binding to the 50S ribosomal subunit of bacteria and inhibiting peptidyl transferase. This enzyme catalyzes the growing polypeptide chain by forming the peptide bonds between adjacent amino acids [7]. The topical application of Chloramphenicol is known to be relatively safe, but its systemic administration may have fatal side effects, such as aplastic anemia and bone marrow suppression [8]. Because of this reason, chloramphenicol use is restricted to ophthalmic applications or other infection treatment when the alternative treatments are not available [9]. The chloramphenicol has treated of 91% to 93% in ocular infections [12, 13] and can inhibit more than 94% of eye pathogens [10]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have